Niels van Namen - executive vice president, Healthcare at CEVA Logistics and Stephen Barksfield - global BD program director, Healthcare at CEVA Logistics look at how logistics is affecting the future pipeline of pharma.
In this episode we speak to Professor David Nutt about his recent decision to join the biotech Awakn Life Sciences to help the company bring about a change to mental health treatments through the use of psychedelic medicines.
Roy Butcher, procurement manager at Southgate Packaging looks at the latest trends in anti-counterfeiting packaging technologies and how Covid-19 has played a major role in product innovation.
Adrienne Rivlin, Partner, and Jess Sharpe, Associate, at L.E.K. Consulting assess the rise in investment seen within the psychedelics market for mental health.
Sue Ellison, joint MD of OPM (labels and packaging) Group looks at how counterfeiting measures for pharmaceuticals packaging are being affected in a post-Brexit world.
Pedro Lichtinger, CEO and chairman of biotech Starton Therapeutics, speaks to EPM about the company’s mission to improve cancer care using transdermal technology.
For World Heart Day Ian Bolland speaks to Johnson & Johnson and the University of Leicester about the effects of Atrial Fibrillation on healthcare systems and the technologies and measures that can be put into place to treat the condition.
